U.S. Patent Office Grants Interim Extension for SURFAXIN Patent

Summary

The U.S. Patent and Trademark Office has issued an order granting a second one-year interim extension under 35 U.S.C. 156(d)(5) for the term of U.S. Patent No. 5,407,914, which covers the SURFAXIN drug, until a later date to be determined.